In an in vivo nude mice xenograft model 40 mg/kg b.w. luteolin i.p., three times a week, enhanced the cancer therapeutic activity of cisplatin via p53 stabilization and accumulation; mean tumor weight after three weeks was reduced from 1.28 g to 0.46 g. Here, TP53 is linked to neoplasm.